ConductScience.org, home

Paper7987997

A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.

Stöger H and 9 others. Cancer Chemother Pharmacol, 1994. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients. Papers, record 7987997. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7987997

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase I, Clinical Trial, Phase II, Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2018-11-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stöger HH
2Bauernhofer TT
3Schmid MM
4Ploner FF
5Moser RR
6Derstvenscheg EE
7Steindorfer PP
8Wilders-Truschnig MM
9Kuss II
10Samonigg HH

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Breast NeoplasmsMajor topic
DoxorubicinMajor topic
FluorouracilMajor topic
LeucovorinMajor topic
Adult
Aged
Diarrhea
Drug Administration Schedule
Female
Humans
Leukopenia
Middle Aged
Nausea

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16341335Chemotherapy of breast cancer: current views and results.Int J Radiat Oncol Biol Phys1983https://conductscience.org/library/papers/6341335PubMed
2496103Risk factors for doxorubicin-induced congestive heart failure.Ann Intern Med1979https://conductscience.org/library/papers/496103PubMed
323697944'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2369794PubMed
43517242Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.J Clin Oncol1986https://conductscience.org/library/papers/3517242PubMed
53963850[Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3963850PubMed
6528373Tetrahydropyranyl derivatives of daunomycin and adriamycin.J Antibiot (Tokyo)1979https://conductscience.org/library/papers/528373PubMed
73501543Preliminary results of a phase II trial for the treatment of metastatic breast cancer with 5-fluorouracil and leucovorin.NCI Monogr1987https://conductscience.org/library/papers/3501543PubMed
83874000Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.Chemioterapia1985https://conductscience.org/library/papers/3874000PubMed
96424579[Chemical modification of anticancer agents from viewpoints of their pharmacokinetics].Gan To Kagaku Ryoho1984https://conductscience.org/library/papers/6424579PubMed
103162456Phase I study of pirarubicin.J Cancer Res Clin Oncol1988https://conductscience.org/library/papers/3162456PubMed
117049347Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial.Cancer1982https://conductscience.org/library/papers/7049347PubMed
122443619
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
J Clin Oncol1987https://conductscience.org/library/papers/2443619PubMed
133947112[A phase II study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies. THP Study Group].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3947112PubMed
143547667New agents and new medical treatments for advanced breast cancer.Semin Oncol1987https://conductscience.org/library/papers/3547667PubMed
151107570Adriamycin-a review.J Natl Cancer Inst1975https://conductscience.org/library/papers/1107570PubMed
162661735Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.J Clin Oncol1989https://conductscience.org/library/papers/2661735PubMed
17912660Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.Cancer1977https://conductscience.org/library/papers/912660PubMed
186985698Cancer of the breast: the past decade (first of two parts).N Engl J Med1980https://conductscience.org/library/papers/6985698PubMed
193954376[Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].Gan To Kagaku Ryoho1986https://conductscience.org/library/papers/3954376PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7987997

GET https://conductscience.org/api/papers/v1/7987997/authors